Sitemap
Pages
- Comprehensive and Flexible Clinical Data Management Services now Using MEDIDATA RAVE
- Contact Us
- Our Solutions
- Resources
- Why IDDI
- Home
- Careers
- Privacy Statement
- Cookie Policy
- Search
- Sitemap
Posts by category
- Category: Homepage Featured Webinar
- Good Morning Meeting | Promise and Perils of Subgroup Analysis in Early Drug Development
- GPC – A novel statistical method for outcome analysis and reporting of prioritized composite endpoints
- Supporting Shared Decision-making and Communication in Breast Cancer: The ShareView Project
- The Added Value of Biostatistics-Driven Randomization and Trial Supply Management System (RTSM)
- Why Do So Many Phase III Clinical Trials Fail?
- Optimizing Rare Disease Trials: Trial Design & Execution
- The Benefit-Risk Assessment of New Treatments: The Health Technology Assessment (HTA) Process
- Conversation between a Sponsor and a Statistician about Phase II/III trials in oncology
- Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
- Assessing activity in early-phase trials in oncology: current designs for expansion cohorts and phase 2
- Biostatistics and SARS-CoV-2: research, policymaking, and communication
- Category: News
- Happy Holiday Season
- IDDI at SRIW Life Sciences’ Workshop
- IDDI at Eyecelerator AAO 2022
- IDDI speaking at Precision in Clinical Trials Summit 2022
- IDDI at BIOForward 2022
- IDDI at Fierce Biotech Summit 2022
- IDDI at Rocky Mountain Life Sciences Investor & Partnering Conference 2022
- IDDI at SCDM 2022 Annual Conference
- IDDI at PCMG 2022 Annual Outsourcing Assembly
- Lunch & Learn Workshop
- Integrating Technology and Expertise
- SCRIP Awards
- Sample Size Re-Estimation as an Adaptive Design
- IDDI Sponsor at Gene Therapy for Ophthalmic Disorders Digital Conference
- Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints
- IDDI at the PCMG Annual Conference 2021
- IDDI at NLSDays 2021
- IDDI Speaker at DIA 2021
- IDDI Speaker at the Precision Medicine and Health Technology Assessment Webinar
- IDDI speaker at 2021 ASA Regulatory Industry Statistics Workshop (RISW)
- IDDI speaking at the Annual Meeting of the Society for Clinical Trials (SCT)
- IDDI at the 4th Annual Next Gen Immuno-Oncology Virtual Congress
- DIA EUROPE – ADaM Specifications for Statistical Reporting: Making Documentation Almost Fun
- Seminar: Missing data. Should I care?
- Looking back, thinking ahead: industry leaders talk trends
- Happy Holiday Season from the IDDI Team
- Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer
- 2021 Year in Preview: The Year to Come and the Year That Was
- IDDI Complimentary Breakfast Webinar
- Medicon Valley Alliance: Q&A Interview with Erik Falvey from IDDI
- ECCRT and IDDI establish partnership for continuous development
- SCDM 2020 Virtual Conference
- Meet us at the Knowledge For Growth virtual event
- Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors
- IDDI published an editorial on non-inferiority trials
- Statistical Aspects in Adjuvant and Neoadjuvant Trials for Gastrointestinal Cancer in 2020: Focus on Time-To-Event Endpoints
- A message from IDDI’s CEO Damien Tremolet on COVID-19
- IDDI at CLINICAL OPERATIONS IN ONCOLOGY TRIALS EAST COAST 2020
- Best Wishes for 2020
- IDDI at Clinical Operations in Oncology Trials East Coast 2019
- IDDI announces the Appointment of a New Chief Commercial Officer
- IDDI Speaker at EFSPI Meeting
- IDDI at DIA Annual Global Meeting
- IDDI at Clinical Operations in Oncology Trials East Coast 2018
- IDDI at 2nd Clinical Trials Nexus (CTN)
- IDDI at 6th Oncology Strategy Meeting USA
- IDDI at CDISC Europe Interchange 2018
- IDDI at IRT Europe 2018
- IDDI at ENAR Spring Meeting
- IDDI at Jobday-Sciences ULB 2018
- IDDI appoints Dr. Jean-Pierre Bizzari as a new Board Member
- Best Wishes for 2018!
- IDDI at ASCO Meeting
- Category: News & Events
- IDDI at BIO International Convention 2023
- IDDI at PCMG Annual Assembly 2023
- IDDI speaking at KCE Trials Symposium 2023
- IDDI at CNS THERAPEUTICS XCHANGE EAST COAST 2023
- IDDI at Knowledge for Growth 2023
- IDDI at Outsourcing In Clinical Trials East Coast 2023
- IDDI at Clinical Trials Strategic Summit EU 2023
- IDDI at Clinical Trials Strategic Summit 2023
- IDDI presenting at ISPOR 2023
- IDDI at OCT Europe 2023
- ASCO 2023 – Meet IDDI Oncology Experts
- IDDI at ARVO Annual Meeting 2023
- IDDI at Swiss Biotech Day 2023
- IDDI at BioTrinity 2023
- IDDI at Clinical Operations in Oncology Trials West Coast 2023
- IDDI at COG New England 2023
- IDDI at OCT Southeast 2023
- IDDI at Clinical Research Day 2023 by AFCROs
- IDDI at OCT West Coast 2023
- IDDI at COG UK 2023
- IDDI speaking at National Academies of Sciences, Engineering, and Medicine’s Workshop
- IDDI Newsletter – January 2023
- IDDI at JP Morgan Week 2023
- IDDI appoints Linda Danielson as its new Chief Executive Officer
- IDDI at Outsourcing in Clinical Trials DACH 2022
- IDDI exhibiting at Clinical Operations in Oncology Trials Europe 2022
- IDDI at Precision In Clinical Trials Summit 2022
- IDDI at Proventa International’s 6th Annual Oncology Strategy Meeting 2022
- IDDI at Clinical Trials Europe 2022
- IDDI at the DIA Innovative Trial Designs Conference 2022
- IDDI presenting at MSKCC Biostatistics Seminar Series
- IDDI speaking at European Statistical Forum 2022
- IDDI sponsors Clinical Trials Strategic Summit 2022
- IDDI at OCT Nordics 2022
- IDDI at BIO Europe 2022
- IDDI sponsors PharmaSUG SDE NC 2022
- IDDI at HealthTech Innovation Days 2022
- IDDI Newsletter – August 2022
- IDDI at Outsourcing in Clinical Trials Southern California 2022
- IDDI announces RTSM partnership with Clario
- IDDI at Clinical Operations in Oncology Trials East Coast 2022
- IDDI speaking at the 2022 Joint Statistical Meetings (JSM)
- IDDI speaking at the 9th Statistics & Biopharmacy Conference (SnB2022)
- IDDI speaker at Congress SFPT 2022
- IDDI at BIO International Convention 2022
- IDDI at DIA Global Annual Meeting 2022
- IDDI at Outsourcing in Clinical Trials East Coast 2022
- IDDI at Knowledge for Growth 2022
- IDDI at Outsourcing in Clinical Trials Europe 2022
- Good Morning Meeting | Generalized Pairwise Comparisons (GPC): An innovative statistical method to design and analyze clinical trials
- IDDI at Outsourcing in Clinical Trials Southeast 2022
- IDDI at Clinical Research Day #JRC2022 by AFCROs
- IDDI at DIA EUROPE 2022
- Assessing treatment efficacy in early-phase oncology trials
- Happy Holiday Season
- IDDI becomes a Medidata Rave EDC Partner
- IDDI partner in the ShareView project
- IDDI Newsletter – November 2021
- IDDI 30 YEAR ANNIVERSARY
- IDDI at Outsourcing in Clinical Trials DACH & Western 2021
- IDDI sponsors the 2nd Annual Dry AMD Therapeutic Development Summit
- IDDI at Outsourcing in Clinical Trials and Clinical Trials Supply Nordics 2021
- Phase I trials in oncology: Pros and cons of current designs
- IDDI at BeCRO CRO vs Pharma/Biotech/MD battle event
- IDDI at OIS Retina Innovation Summit 2021
- IDDI at HealthTech Innovation Days 2021
- ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
- IDDI at the 5th Annual Next Gen Immuno-Oncology Virtual Congress
- IDDI at Knowledge for Growth 2021
- IDDI Faculty Member at the Global Congress on Prostate Cancer (PROSCA)
- IDDI Newsletter – July 2021
- Webinar: Randomization and the Limits of Precision Oncology
- Clinical Development Trends
- IDDI Supporting Cancer Charity Associations
- NEWSLETTER NOVEMBER 2020
- Epidemiology, Methodology, and Clinical Research in the midst of the COVID-19 pandemic
- IDDI at Biomarker and Companion Diagnostics Virtual Conference
- NEWSLETTER APRIL 2020
- Newsletter August 2020
- IDDI Member of the Medicon Valley Alliance
- Assessing Treatment Benefit in Immuno-oncology
- IDDI at DIA Global Annual Meeting
- IDDI at Clinical Operations online strategy meeting
- IDDI at the Online Oncology Strategy Meeting
- IDDI at BIO US Digital
- IDDI supports Covid-19km challenge
- IDDI Management of your trials during Covid-19 Pandemic
- NEWSLETTER APRIL 2020
- Project Manager
- IDDI at Biotech Showcase 2020
- SYMPOSIUM: Are Randomized Trials Obsolete?
- Newsletter – November 2019
- IDDI at Clinical Operations in Oncology Trials West Coast 2020
- IDDI at Outsourcing in Clinical Trials Southeast 2020
- IDDI at MassBio’s Annual Meeting 2020
- IDDI AT BIO-EUROPE SPRING 2020
- IDDI at DIA EUROPE 2020
- IDDI at Clinical Operations in Oncology Trials Southern California 2020
- IDDI at the 5th Annual Biomarker & Companion Diagnostics
- IDDI at EUCROF 2020
- IDDI at 9ème Journée de la Recherche Clinique
- IDDI Speaking at Cancer Precision Medicine Forum
- IDDI at ISPOR Europe 2019
- IDDI at Bio Europe 2019
- IDDI at Clinical Trial Supply East Coast
- IDDI at Outsourcing in Clinical Trials Nordics 2019
- IDDI LUNCH & LEARN WORKSHOP
- IDDI at Clinical Trial Supply Chain Strategy Europe
- IDDI at OIS AAO 2019
- IDDI Sponsor at the ISCB Conference
- IDDI Supports Clinical Trials Awareness Week
- Meet IDDI at ASCO Annual Meeting 2019
- IDDI at Outsourcing in Clinical Trials East Coast
- IDDI at Outsourcing in Clinical Trials Europe 2019
- IDDI at Knowledge for Growth 2019
- IDDI at Clinical Operations in Oncology Trials West Coast
- IDDI at MassBio Annual Meeting 2019
- IDDI Supports World Cancer Day
- IDDI at Proventa Oncology Strategy Meeting
- IDDI at Outsourcing in Clinical Trials Southeast
- IDDI at Outsourcing in Clinical Trials West Coast 2019
- IDDI at DIA EUROPE 2019
- IDDI at AFCROs Conference
- Collaborative Research on Statistical Method for Individualization of Therapy
- Best wishes for 2019
- Saint Nicolas at IDDI
- IDDI Comment on the FDA Draft Guidance on Expansion Cohorts
- JOINT UCL-IDDI WORKSHOP
- IDDI at Biowin Day 2018
- IDDI at Outsourcing in Clinical Trials New England 2018
- IDDI at Outsourcing in Clinical Trials DACH 2018
- IDDI at Oncology Strategy Meeting US East Coast 2018
- Meet our Experts at ESMO 2018
- IDDI Sponsor at IRT 2018 USA
- IDDI Open House & Scientific Symposium
- Oncology Clinical Trials: Successful Design, Conduct, and Analysis
- IDDI at ASCO 2018
- IDDI at Phuse US 2018
- IDDI at PSI Conference 2018
- IDDI at Knowledge for Growth
- IDDI at ACDM Annual Conference 2018
- IDDI at Clinical Operations in Oncology Trials Europe
- IDDI at 2017 CDISC International Interchange
- IDDI shareholding moving forward!
- IDDI Sponsor at the Oncology Strategy Meeting 2017
- IDDI at 7th Annual IRT 2017
- IDDI at Outsourcing in Clinical Trials Nordics 2017
- IDDI at 2017 DMC Optimization Summit
- IDDI at SCDM 2017
- IDDI at Outsourcing in Clinical Trials 2017
- IDDI at 2nd Ophthalmic Drug Development Summit
- IDDI at Clinical Operations in Oncology Trials East Coast
- IDDI at the 8th Clinical Trials Innovation Programme (CTIP)
- IDDI at Proventa Oncology Strategy Meeting West Coast
- IDDI at Knowledge for Growth 2017
- IDDI at Outsourcing in Clinical Trials Israel
- Applied Surrogate Endpoint Evaluation Methods with SAS and R
- Biowin Supports the Smart Project
- System Validation Specialist
- Lead Clinical Data Manager
- Clinical Data Management Programming Specialist
- Statistical Programmer
- Biostatistician
- IDDI at Biotech Showcase 2017
- IDDI 25th Anniversary
- FDA signs CRADA with CluePoints
- Project Manager
- Category: Scientific Conferences
- Central Statistical Monitoring of Clinical Trials
- Treatment Effect in Clinical Trials
- Efficient Statistical Detection of Fraud in Multicentre Experiments.
- Surrogate Endpoint Validation
- Statistical Assessment of Potential Surrogate Endpoints
- Generalized Pairwise Comparisons
- Surrogate endpoints validation and applications
- Designs Adaptatifs en Oncologie
- Clinical Trial Methodology
- A Valid Surrogate Endpoint for Event-Free Survival
- Generalized Pairwise Comparisons for Personalized Medicine
- Generalized Pairwise Comparisons for Personalized Medicine
- Open Sharing of Clincal Trial Data
- Designs Adaptatifs en Oncologie
- Clinical Trial Methodology
- Clinical trial methodology
- Novel Trial Endpoints: Opportunities and Challenges for New Surrogate Endpoints
- Statistical interpretation of trials in digestive oncology
- Tumor Size Nadir and Time to Nadir as Surrogates for OS in Patients on 1st Line Treatment for mCRC
- Tumor-Size-Based Endpoints as Surrogates For Overall Survival
- Clinical Trial Methodology
- Computer Intensive Statistical Assessment of Data Quality in Clinical Trials
- Dan Sargent as Leader, Researcher, Colleague and Mentor
- Designs Adaptatifs En Oncologie – Quand? Pourquoi? Comment?
- The Potential And Perils Of Observational Studies
- A Statistical Approach to Central Monitoring of Clinical Trial Data
- Generalized Pairwise Comparisons To Test Cancer Immunotherapies
- Design and conduct of Oncology Clinical Trials
- Analyzing Multiple Endpoints Simultaneously In Crossover Trials
- Statistical Interpretation And Validity of Clinical Trials
- Beyond Hazard Ratios
- Generalized Pairwise Comparisons
- The Surrogate Threshold Effect For Event-Free Survival As A Potential Surrogate For Overall Survival
- Statistical Issues in Umbrella Trials
- Adaptive Design-Yes! Adaptive Randomization-No!
- Subgroup Analysis in Clinical Trials: Where Are We Now?
- Category: Jobs
- IT Support Specialist
- Junior Clinical Data Management EDC Specialist
- Manager of Statistical Programming
- Marketing Specialist
- Experienced Clinical Data Manager BE
- Junior Clinical Data Manager USA
- Senior Scientist – Statistical Consulting USA
- Senior Scientist – Statistical Consulting BE
- Statistical Programmer
- Senior Biostatistician
- Senior Biostatistician – Consulting Services
- Senior Biostatistician
- Category: Vacancies USA
- Category: Vacancies Belgium
- Category: Resources
- eBook: The Ultimate Guide to Clinical Data Management
- Adapting the Randomization Algorithm
- Adding a stratification factor during the study
- Optimizing the Drug Supply Strategy
- Why do so Many Phase III Fail?
- Estimands in Oncology: Are we censoring for the right reason?
- SOCRATES (Standard of Care Randomized Trials) and the need for big randomized data.
- Designing a randomized trial with sample-size re-estimation: Challenges and Best Practices
- Bias and Randomization 1980 – 2020 – 2060
- Demystifying Clinical Systems Integration
- Webinar: Clinical Trials for, and despite, COVID-19
- Companion diagnostics and clinical development in oncology: a statistical perspective
- Clinical endpoints and treatment effect in immuno-oncology
- THE IMPACT OF COVID-19 ON RANDOMIZED CLINICAL TRIALS
- Webinar: Minimization: A Flexible Randomization Method
- Webinar: Data-Driven eTMF and Clinical Data Management – An Integrated Approach
- Bayesian Outcome-Adaptive Randomization Designs
- Expansion Cohorts in Early Development of Anticancer Agents
- IDDI Comments on FDA Draft Guidance on Expansion Cohorts
- Assessing Treatment Benefit in Immuno-Oncology
- Biostatistical Challenges of Trials in Rare Diseases
- A New Statistical Method: Generalized Pairwise Comparisons
- Treatment Allocation in Randomized Trials: Challenges and Best Practices
- Tumor-Size-Based Measurements as Endpoint in Cancer Clinical Trials
- Incorporating Health Technology Assessment (HTA) in Clinical Trials
- Current Status of Surrogates for Survival in Cancer Trials
- Personalized Cancer Medicine Needs Randomized Trials
- Patient-Level Data Sharing in Clinical Research
- From Biomarkers to In-vitro Companion Diagnostic Device
- Future of Cancer Clinical Trials
- Data Monitoring Committees (DMC) Best Practices
- Implementing Adaptive Trials: Operational Considerations
- Pros and Cons of Adaptive Designs
- Efficient Designs in Phase I Trials in Oncology
- Fruitful Sponsor/CRO Collaboration: How to Succeed
- The Need for Better Endpoints: Towards a More Efficient Drug Development in Oncology
- Central Statistical Monitoring of Clinical Trials
- Designs of Non-Inferiority and Biosimilar Clinical Trials
- Achieving Efficiency in Clinical Data Collection
- Biomarker-Based Clinical Trial Designs
- Statistical Validation of Biomarkers
- Development and Validation of Clinically Useful Gene Signatures
- Operational Aspects of Data Monitoring Committees
- Design and Analysis of Phase II Trials in Oncology
- IDDI Announces The Appointment of Dr. Everardo Saad as Senior Medical Expert
- IDDI Simplifies Collaboration with Veeva Systems’ Vault eTMF Solution
- CluePoints Launches Powerful & Pragmatic Solution to Risk-Based Monitoring
- IDDI – XClinical: The best of Two Worlds
- IDDI Announces Collaborative Agreement with I-Biostat
- IDDI Reports Successful Partnership with Tigenix for Approval of Chondrocelect
- Category: Videos
- Category: Brochures
- Generalized Pairwise Comparisons – GPC
- Overview of IDDI Clinical Trial Services
- Clinical Biostatistics Services
- Integrated eClinical Solutions
- Oncology CRO
- Consultancy Services
- Interim Analyses – IDMC’S Support
- CDISC SDTM-ADaM Data Conversion Services
- Clinical Data Management Solutions
- Ophthalmology Services
- Randomization Services
- ID-Code – Medical Coding Services
- Statistical Biomarker Validation
- Data management for Adaptive Monitoring – KRIs
- IDDI Experience in Statistical Analyses of Biomarkers, Gene Signatures and Proteomics
- Category: Case Studies
- Meeting randomization & clinical supply challenges head-on
- Overcoming Clinical Trial Design Challenges in a Phase I/II Phase Myelodysplastic syndrome study
- Case study: The REALI pooled analysis of the European post-marketing studies for the TOUJEO® product
- Overcoming the challenges of Collaborative Global Trials to deliver Harmonized SAS SDTM Database
- A Single Front-End For EDC and Randomization
- Independent Analyses To Inform Go/No-go Decisions
- Clinical Validity Of Circulating Tumor Cells (CTC)
- A Double Masked Minimization in Ophthalmology Study
- Developing New Biomarkers And Diagnostic Tests
- Bayesian Study Design
- Flexible Study Design
- Discovering New Prognostic Biomarkers For Breast Cancer
- Meta-Analysis To Assess Efficacy in Colorectal Cancer
- Applying Likelihood Method For Data Safety Monitoring
- Validation of a Genetic Signature For Women With Node-Negative Breast Cancer
- Validating Adverse Events On A Large Scale
- Jumping Ahead to Phase III trial
- Analyzing a Biomarker As A Proof Of Concept
- Meta-Analysis of Clinical Trials to Support New Drug Approval
- Anti-cancer drug approved based on a surrogate endpoint
- Using Minimization for a Complex Trial Design
- Category: Featured Articles
- Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in HER2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–HER2 Therapy
- Immunotherapy against cancer: Challenge and opportunities
- Drug Development in Oncology in the Era of Precision Medicine
- The Importance of Early Phase Trials in Precision Oncology
- Considerations on the mechanics and sample sizes for early trials of targeted agents and immunotherapy in oncology
- Personalized Medicine: A Work in Progress
- Commanders & Chiefs: Clinical Services C-Suite – Pharmavoice
- Finding the one: How to choose a Clinical Partner in Sea of Service Providers
- Integration of Biomarker Validation in Clinical Development in Oncology
- IDDI in Contract Pharma
- Surrogate endpoints create potential, require statistical validation
- Using disease free survival as a primary endpoint in early breast cancer
- IDDI: coup de pouce à la médecine personnalisée
- Personalized Medicine: Getting More Out of Clinical Trials
- IDDI, Fleuron Statistique pour les Biotechs Wallonnes
- They Are Talking About IDDI
- A Central Statistical Monitoring of Data Quality in Clinical Trials
- Category: Podcasts
- How Generalized Pairwise Comparisons can help reducing sample size in clinical trials
- AN INNOVATIVE STATISTICAL METHODOLOGY
- LEVERAGING IDDI’S CLINICAL DATA MANAGEMENT EXPERTISE
- The Value of Statistically driven RTSM Solutions
- The Importance of IDDI’s Full Service Delivery – From a Project Management Point of View
- The Impact of COVID-19 on Randomized Clinical Trials
- Biostatistics & Data Management: combined services ensuring you meet your study goals!
- Podcast: IDDI Services
- Category: Webinars
- Category: White papers
- Category: Testimonials
- Valuable consultancy services
- Reached internal consensus quickly
- System build timelines are the fastest of any vendor
- Switching from paper CRFs to EDC
- EDC system goes live in a short amount of time
- IDDI shows commitment to quality and precision
- Outstanding statistical work
- Fast EDC Database Go-Live
- EDC Go-Live in Short Timelines
- Flexibility to IDMC Request
- Time Effective Clinical Trials
- Helpful Helpdesk
- Flexibility and Responsive Team
- Responsive and Professional Team